{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:07:49Z","timestamp":1770286069052,"version":"3.49.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.jcyt.2021.11.006","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T02:10:10Z","timestamp":1645841410000},"page":"516-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effectiveness of cell- and colony stimulating factor-based therapy for liver cirrhosis: a network meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"24","author":[{"given":"Xiaojun","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0722-8019","authenticated-orcid":false,"given":"Shilei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcyt.2021.11.006_bib0001","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jhep.2016.11.014","article-title":"Human liver regeneration in advanced cirrhosis is organized by the portal tree","volume":"66","author":"Dezso","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0002","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10456-020-09751-9","article-title":"3D analysis of microvasculature in murine liver fibrosis models using synchrotron radiation-based microtomography","volume":"24","author":"Wagner","year":"2021","journal-title":"Angiogenesis"},{"issue":"3","key":"10.1016\/j.jcyt.2021.11.006_bib0003","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"5","author":"Collaborators","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0004","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/lt.25361","article-title":"Increasing Incidence of Nonalcoholic Steatohepatitis as an Indication for Liver Transplantation in Australia and New Zealand","volume":"25","author":"Calzadilla-Bertot","year":"2019","journal-title":"Liver Transpl"},{"issue":"8","key":"10.1016\/j.jcyt.2021.11.006_bib0005","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3390\/genes12081274","article-title":"Disparity of Hepatocellular Carcinoma in Tumor Microenvironment-Related Genes and Infiltrating Immune Cells between Asian and Non-Asian Populations","volume":"12","author":"Huang","year":"2021","journal-title":"Genes (Basel)"},{"issue":"5","key":"10.1016\/j.jcyt.2021.11.006_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232516","article-title":"Regional citrate anticoagulation versus no-anticoagulation for continuous venovenous hemofiltration in patients with liver failure and increased bleeding risk: a retrospective case-control study","volume":"15","author":"Yu","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0007","doi-asserted-by":"crossref","first-page":"14506","DOI":"10.1038\/s41598-021-93881-7","article-title":"Comparison of liver biopsies before and after direct-acting antiviral therapy for hepatitis C and correlation with clinical outcome","volume":"11","author":"Saldarriaga","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0008","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/hep.31012","article-title":"Grade 1 Acute on Chronic Liver Failure Is a Predictor for Subsequent Grade 3 Failure","volume":"72","author":"Mahmud","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0009","doi-asserted-by":"crossref","first-page":"20176","DOI":"10.1038\/s41598-020-77235-3","article-title":"A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1136\/gutjnl-2020-322161","article-title":"Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis","volume":"71","author":"Mezzano","year":"2022","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.jcyt.2021.11.006_bib0011","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/hep.30494","article-title":"Incidence and Mortality of Acute-on-Chronic Liver Failure Using Two Definitions in Patients with Compensated Cirrhosis","volume":"69","author":"Mahmud","year":"2019","journal-title":"Hepatology"},{"issue":"1-2","key":"10.1016\/j.jcyt.2021.11.006_bib0012","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/pr.2017.284","article-title":"Human hepatocyte transplantation for liver disease: current status and future perspectives","volume":"83","author":"Iansante","year":"2018","journal-title":"Pediatr Res"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0013","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12916-018-1110-y","article-title":"Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation","volume":"16","author":"Samuel","year":"2018","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0014","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13613-020-00795-0","article-title":"Uncertainty in the impact of liver support systems in acute-on-chronic liver failure: a systematic review and network meta-analysis","volume":"11","author":"Ocskay","year":"2021","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jcyt.2021.11.006_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4197857","article-title":"Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis","volume":"2018","author":"Kwak","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0016","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1186\/s13287-020-01911-4","article-title":"Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis","volume":"11","author":"Su","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0017","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S2468-1253(17)30359-X","article-title":"Haemopoietic stem cell therapy in cirrhosis: the end of the story?","volume":"3","author":"Lanthier","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.jcyt.2021.11.006_bib0018","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1586\/17474124.2016.1134313","article-title":"Cell transplantation as a non-invasive strategy for treating liver fibrosis","volume":"10","author":"Matsumoto","year":"2016","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0019","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12967-018-1464-0","article-title":"Clinical performance of stem cell therapy in patients with acute-on-chronic liver failure: a systematic review and meta-analysis","volume":"16","author":"Xue","year":"2018","journal-title":"J Transl Med"},{"issue":"10","key":"10.1016\/j.jcyt.2021.11.006_bib0020","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/MEG.0000000000001455","article-title":"Autologous stem cell transplantation for patients with viral hepatitis-induced liver cirrhosis: a systematic review and meta-analysis","volume":"31","author":"Chen","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0021","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13287-020-01627-5","article-title":"Autologous bone marrow stem cell transplantation via the hepatic artery for the treatment of hepatitis B virus-related cirrhosis: a PRISMA-compliant meta-analysis based on the Chinese population","volume":"11","author":"Sun","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"10.1016\/j.jcyt.2021.11.006_bib0022","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1665-2681(19)30757-4","article-title":"Granulocyte-colony stimulating factor for acute-on-chronic liver failure: systematic review and meta-analysis","volume":"14","author":"Chavez-Tapia","year":"2015","journal-title":"Ann Hepatol"},{"issue":"2","key":"10.1016\/j.jcyt.2021.11.006_bib0023","first-page":"90","article-title":"Effects of Granulocyte Colony-Stimulating Factor on Patients with Liver Failure: a Meta-Analysis","volume":"4","author":"Yang","year":"2016","journal-title":"J Clin Transl Hepatol"},{"issue":"9","key":"10.1016\/j.jcyt.2021.11.006_bib0024","first-page":"e10474","article-title":"Efficacy of Granulocyte Colony Stimulating Factor in Severe Alcoholic Hepatitis: A Systematic Review and Meta-Analysis","volume":"12","author":"Baig","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.jcyt.2021.11.006_bib0025","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jcyt.2021.11.006_bib0026","doi-asserted-by":"crossref","first-page":"m4573","DOI":"10.1136\/bmj.m4573","article-title":"Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials","volume":"372","author":"Palmer","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.jcyt.2021.11.006_bib0027","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2468-1253(19)30324-3","article-title":"Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis","volume":"5","author":"Black","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jcyt.2021.11.006_bib0028","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cgh.2020.02.022","article-title":"Multiple Cycles of Granulocyte Colony-Stimulating Factor Increase Survival Times of Patients With Decompensated Cirrhosis in a Randomized Trial","volume":"19","author":"De","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0029","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/liv.13923","article-title":"Early cirrhosis and a preserved bone marrow niche favour regenerative response to growth factors in decompensated cirrhosis","volume":"39","author":"Anand","year":"2019","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.jcyt.2021.11.006_bib0030","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/hep.29763","article-title":"Outcomes after multiple courses of granulocyte colony-stimulating factor and growth hormone in decompensated cirrhosis: a randomized trial","volume":"68","author":"Verma","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jcyt.2021.11.006_bib0031","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MEG.0000000000000801","article-title":"Granulocyte colony-stimulating factor improves survival of patients with decompensated cirrhosis: a randomized-controlled trial","volume":"29","author":"Prajapati","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.jcyt.2021.11.006_bib0032","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1053\/j.gastro.2015.02.054","article-title":"Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis","volume":"148","author":"Kedarisetty","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jcyt.2021.11.006_bib0033","first-page":"e15447","article-title":"Granulocyte colony stimulating factor adjuvant role on the immunological response to hepatitis B vaccine in patients with cirrhosis: a double blind randomized placebo controlled trial","volume":"14","author":"Lankarani","year":"2014","journal-title":"Hepat Mon"},{"issue":"3","key":"10.1016\/j.jcyt.2021.11.006_bib0034","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/j.gastro.2011.11.027","article-title":"Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure","volume":"142","author":"Garg","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hep.22317","article-title":"Granulocyte-colony stimulating factor induces proliferation of hepatic progenitors in alcoholic steatohepatitis: a randomized trial","volume":"48","author":"Spahr","year":"2008","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.jcyt.2021.11.006_bib0036","doi-asserted-by":"crossref","first-page":"e9728","DOI":"10.1590\/1414-431x20209728","article-title":"A novel stem cell therapy for hepatitis B virus-related acute-on-chronic liver failure","volume":"53","author":"Zhu","year":"2020","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0037","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2468-1253(17)30326-6","article-title":"Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial","volume":"3","author":"Newsome","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jcyt.2021.11.006_bib0038","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3904\/kjim.2015.267","article-title":"Ultrasound-guided percutaneous portal transplantation of peripheral blood monocytes in patients with liver cirrhosis","volume":"32","author":"Yu","year":"2017","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jcyt.2021.11.006_bib0039","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4130757","article-title":"Combination Treatments of Plasma Exchange and Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation for Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure: A Clinical Trial in China","volume":"2019","author":"Xu","year":"2019","journal-title":"Stem Cells Int"},{"issue":"3","key":"10.1016\/j.jcyt.2021.11.006_bib0040","first-page":"268","article-title":"Autologous Bone Marrow Stem Cell Transplantation in Liver Cirrhosis after Correcting Nutritional Anomalies, A Controlled Clinical Study","volume":"21","author":"Esmaeilzadeh","year":"2019","journal-title":"Cell J"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0041","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.29189","article-title":"Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: A randomized controlled trial","volume":"66","author":"Lin","year":"2017","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.jcyt.2021.11.006_bib0042","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1002\/hep.28693","article-title":"Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial","volume":"64","author":"Suk","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0043","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5966\/sctm.2015-0004","article-title":"Intraportal Infusion of Bone Marrow Mononuclear or CD133+ Cells in Patients With Decompensated Cirrhosis: A Double-Blind Randomized Controlled Trial","volume":"5","author":"Mohamadnejad","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2021.11.006_bib0044","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13287-015-0106-1","article-title":"The impact of repeated autologous infusion of haematopoietic stem cells in patients with liver insufficiency","volume":"6","author":"Zekri","year":"2015","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"10.1016\/j.jcyt.2021.11.006_bib0045","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/jgh.12653","article-title":"Randomized trial of autologous bone marrow mesenchymal stem cells transplantation for hepatitis B virus cirrhosis: regulation of Treg\/Th17 cells","volume":"29","author":"Xu","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jcyt.2021.11.006_bib0046","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/scrt459","article-title":"Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease","volume":"5","author":"Salama","year":"2014","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0047","doi-asserted-by":"crossref","first-page":"e53719","DOI":"10.1371\/journal.pone.0053719","article-title":"Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial","volume":"8","author":"Spahr","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"10.1016\/j.jcyt.2021.11.006_bib0048","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1440-1746.2011.07024.x","article-title":"Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients","volume":"27","author":"Zhang","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0049","first-page":"12","article-title":"Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis","volume":"14","author":"Nikeghbalian","year":"2011","journal-title":"Arch Iran Med"},{"issue":"6","key":"10.1016\/j.jcyt.2021.11.006_bib0050","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.jhep.2021.07.033","article-title":"Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study)","volume":"75","author":"Engelmann","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jcyt.2021.11.006_bib0051","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3662776","article-title":"Bone Marrow Mesenchymal Stem Cells in Acute-on-Chronic Liver Failure Grades 2 and 3: A Phase I-II Randomized Clinical Trial","volume":"2021","author":"Schacher","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.jcyt.2021.11.006_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103193","article-title":"Side effects of using granulocyte-colony stimulating factors as prophylaxis of febrile neutropenia in cancer patients: A systematic review","volume":"157","author":"Lapidari","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"10.1016\/j.jcyt.2021.11.006_bib0053","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5483\/BMBRep.2020.53.3.160","article-title":"Co-administration of erythropoietin and iron complex improves late-phase liver regeneration","volume":"53","author":"Kim","year":"2020","journal-title":"BMB Rep"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0054","doi-asserted-by":"crossref","first-page":"10379","DOI":"10.1038\/s41598-017-11082-7","article-title":"Erythropoietin enhances Kupffer cell number and activity in the challenged liver","volume":"7","author":"Gilboa","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jcyt.2021.11.006_bib0055","first-page":"199","article-title":"Protective effect of erythropoietin against lipopolysaccharide induced inflammation and mitochondrial damage in liver","volume":"32","author":"Zhang","year":"2018","journal-title":"J Biol Regul Homeost Agents"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0056","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s13287-020-01932-z","article-title":"Microparticles derived from human erythropoietin mRNA-transfected mesenchymal stem cells inhibit epithelial-to-mesenchymal transition and ameliorate renal interstitial fibrosis","volume":"11","author":"Lee","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.jcyt.2021.11.006_bib0057","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3109\/00365513.2015.1137351","article-title":"Hepatic erythropoietin response in cirrhosis","volume":"76","author":"Risor","year":"2016","journal-title":"Scand J Clin Lab Invest"},{"issue":"4","key":"10.1016\/j.jcyt.2021.11.006_bib0058","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.clinre.2017.12.001","article-title":"Preoperative erythropoietin treatment improves survival following major hepatic resection in a cirrhotic rat model","volume":"42","author":"Suh","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0059","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/1574888X13666180821160421","article-title":"Paracrine Mechanisms Involved in Mesenchymal Stem Cell Differentiation into Cardiomyocytes","volume":"14","author":"Farzaneh","year":"2019","journal-title":"Curr Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13287-018-0814-4","article-title":"Mesenchymal stem cells: potential application for the treatment of hepatic cirrhosis","volume":"9","author":"Zhang","year":"2018","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"10.1016\/j.jcyt.2021.11.006_bib0061","doi-asserted-by":"crossref","first-page":"562","DOI":"10.21037\/atm.2020.02.119","article-title":"Mesenchymal stem cell therapy for liver fibrosis\/cirrhosis","volume":"8","author":"Cao","year":"2020","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1016\/j.jcyt.2021.11.006_bib0062","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s13287-020-01935-w","article-title":"Therapeutic effect and safety of stem cell therapy for chronic liver disease: a systematic review and meta-analysis of randomized controlled trials","volume":"11","author":"Zhou","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"10.1016\/j.jcyt.2021.11.006_bib0063","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s12072-017-9814-1","article-title":"Therapeutic implications of granulocyte colony stimulating factor in patients with acute-on-chronic liver failure: increased survival and containment of liver damage","volume":"11","author":"Saha","year":"2017","journal-title":"Hepatol Int"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922000068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324922000068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:46:35Z","timestamp":1761443195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324922000068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1465324922000068"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2021.11.006","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of cell- and colony stimulating factor-based therapy for liver cirrhosis: a network meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2021.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}